Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Total Current Liabilities: 2019-2024

Historic Total Current Liabilities for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2024 value amounting to $4.9 million.

  • Benitec Biopharma's Total Current Liabilities rose 104.42% to $7.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $7.0 million, marking a year-over-year increase of 104.42%. This contributed to the annual value of $4.9 million for FY2024, which is 23.78% up from last year.
  • According to the latest figures from FY2024, Benitec Biopharma's Total Current Liabilities is $4.9 million, which was up 23.78% from $4.0 million recorded in FY2023.
  • Over the past 5 years, Benitec Biopharma's Total Current Liabilities peaked at $4.9 million during FY2024, and registered a low of $1.1 million during FY2020.
  • Over the past 3 years, Benitec Biopharma's median Total Current Liabilities value was $4.0 million (recorded in 2023), while the average stood at $3.8 million.
  • As far as peak fluctuations go, Benitec Biopharma's Total Current Liabilities plummeted by 56.99% in 2020, and later skyrocketed by 84.95% in 2022.
  • Yearly analysis of 5 years shows Benitec Biopharma's Total Current Liabilities stood at $1.1 million in 2020, then increased by 20.51% to $1.4 million in 2021, then soared by 84.95% to $2.5 million in 2022, then soared by 57.11% to $4.0 million in 2023, then grew by 23.78% to $4.9 million in 2024.